Heart Disease News and Research

Latest Heart Disease News and Research

Bariatric surgery highly cost-effective treatment for obese type 2 diabetics

Bariatric surgery is an especially cost-effective therapy for managing Type 2 diabetes in moderately and severely obese patients. These findings and others were presented today at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College.

29 Mar 2011

CryoLife to acquire Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.

29 Mar 2011

IOM report recommends steps to ensure LGBT health research gaps and needs

Recent findings on the differences in heart disease among women and men and among blacks and whites show that characteristics such as gender and ethnicity matter when it comes to health research.

29 Mar 2011

People of all ages and both sexes can have congestive heart failure

Elizabeth Taylor died of congestive heart failure at the age of 79 on March 23. Her death raises awareness of this serious condition that affects an estimated five million Americans.

29 Mar 2011

McKesson awards GW with two grants to study mobile-phone use in diabetic patients

GW researchers have been awarded two grants from the McKesson Foundation as part of its Mobilizing for Health initiative, an initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology.

29 Mar 2011

New guidelines highlight genetic testing use in heart arrhythmia clinical management

The Canadian Cardiovascular Society and Canadian Heart Rhythm Society have produced the first-ever comprehensive guidelines on the use of genetic testing in the clinical management of inherited heart rhythm disorders, released in the March/April issue of the Canadian Journal of Cardiology published by Elsevier.

29 Mar 2011

AHA, ACC applaud IOM for its new report on clinical practice guidelines

Few issues are more important to the American College of Cardiology and the American Heart Association than translating scientific evidence into guidelines and performance measures for healthcare providers, a process we have been engaged in for several decades.

29 Mar 2011

Study links specific cardiovascular risk factors to AF episodes

Reducing cardiovascular risk factors like high blood pressure, smoking, diabetes and being overweight could potentially reduce more than half of all cases of atrial fibrillation, according to research reported in Circulation: Journal of the American Heart Association.

29 Mar 2011

Doctors who use iResus application perform better simulated cardiac arrest emergency

Doctors who used a free iPhone application provided by the UK Resuscitation Council performed significantly better in a simulated medical emergency than those who did not, according to a study in the April issue of Anaesthesia.

29 Mar 2011

Study: Donor's DNA level in heart transplant recipient's blood can reveal organ rejection

Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.

29 Mar 2011

IDF: Obese people with type 2 diabetes can benefit from bariatric surgery

Bariatric surgery should be considered earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes, according to an International Diabetes Federation position statement presented by leading experts at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes in New York.

29 Mar 2011

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.

29 Mar 2011

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation or RDN—a procedure that uses a catheter-based probe inserted into the renal artery that emits high-frequency energy to deactivate the nerves near the kidneys that are linked to high blood pressure.

29 Mar 2011

AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions

AmeriCares and AstraZeneca have teamed to deliver critical medicines to help people living with chronic diseases throughout the United States. AstraZeneca has donated $5 million in cardiovascular and gastrointestinal medications to AmeriCares in support of its Domestic Medical Assistance Program.

29 Mar 2011

Altitude Research Center receives Department of Defense grant to prevent AMS in soldiers

As the American military rushes to confront adversaries in some of the world's highest mountain ranges, the Department of Defense is giving $4 million to the Altitude Research Center at the University of Colorado School of Medicine to develop revolutionary ways to combat high altitude sickness in soldiers, sailors and marines.

29 Mar 2011

Study finds 'white coat' hypertension in patients during 24-hour ambulatory monitoring

A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association.

29 Mar 2011

Viewpoints: 'Lesson' from R.I. on waivers; Wis. infant mortality rate disparities; diabetes and seniors

Medicaid is the major cost driver in state budgets these days, so several Governors have proposed a deal to the White House and Congress: They'll take less money in return for the flexibility to run the program with fewer federal strings. A case study in the potential benefits is coming from liberal Rhode Island.

29 Mar 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Bariatric surgery highly cost-effective treatment for obese type 2 diabetics

CryoLife to acquire Cardiogenesis

IOM report recommends steps to ensure LGBT health research gaps and needs

People of all ages and both sexes can have congestive heart failure

McKesson awards GW with two grants to study mobile-phone use in diabetic patients

New guidelines highlight genetic testing use in heart arrhythmia clinical management

AHA, ACC applaud IOM for its new report on clinical practice guidelines

Study links specific cardiovascular risk factors to AF episodes

Doctors who use iResus application perform better simulated cardiac arrest emergency

Study: Donor's DNA level in heart transplant recipient's blood can reveal organ rejection

IDF: Obese people with type 2 diabetes can benefit from bariatric surgery

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions

Altitude Research Center receives Department of Defense grant to prevent AMS in soldiers

Study finds 'white coat' hypertension in patients during 24-hour ambulatory monitoring

Viewpoints: 'Lesson' from R.I. on waivers; Wis. infant mortality rate disparities; diabetes and seniors

Atypical antipsychotics is a safe mental health medication for nursing home residents

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

FDA approves Medtronic's Protecta implantable defibrillators

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in